HomeSYRE • NASDAQ
add
Spyre Therapeutics Inc
Previous close
$15.07
Day range
$14.62 - $15.11
Year range
$10.91 - $40.26
Market cap
905.91M USD
Avg Volume
574.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.94M | -7.02% |
Net income | -44.77M | -2.09% |
Net profit margin | — | — |
Earnings per share | -0.60 | 50.00% |
EBITDA | — | — |
Effective tax rate | 0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 564.82M | 16.54% |
Total assets | 569.78M | 16.85% |
Total liabilities | 87.17M | -74.01% |
Total equity | 482.61M | — |
Shares outstanding | 60.35M | — |
Price to book | 2.78 | — |
Return on assets | -22.73% | — |
Return on capital | -26.77% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -44.77M | -2.09% |
Cash from operations | -40.99M | -43.63% |
Cash from investing | -61.00K | 99.94% |
Cash from financing | 125.00K | -99.93% |
Net change in cash | -40.93M | -205.88% |
Free cash flow | -7.56M | -35.93% |
About
Founded
Jan 1, 2013
Headquarters
Website
Employees
73
